Both in vitro and in vivo blockade of the IL-1α pathway with its natural antagonist IL-1Ra [8] abolished expression of downstream targets of IL-1α and significantly decreased prostate tumor growth and angiogenesis. This evidence concerns the gene IL1A and prostate neoplasm.